Results 211 to 220 of about 5,373,856 (290)
MG‐1 is a bifunctional small molecule that enhances the removal of damaged mitochondria through autophagy, the cell's recycling pathway. Its activity increases under mitochondrial stress, with minimal effects on basal autophagy. MG‐1 also improves movement in a zebrafish model of mitochondrial dysfunction, supporting further investigation of this ...
Ratislav M. Ozhiganov +24 more
wiley +1 more source
Wearable Sensors in Gait Assessment for Parkinson Disease and Stroke in Real-World Environments: Systematic Review and Meta-Analysis. [PDF]
Neumann S +5 more
europepmc +1 more source
Circulating polyethylene microplastic burden is positively associated with heightened ADHD symptom severity and systemic redox‐inflammatory imbalance in children. Mechanistic investigation in a developmental co‐exposure mouse model further demonstrates that microplastics aggravate ADHD‐like behaviors, dopaminergic dysregulation, and oxidative ...
Yufan Luo +12 more
wiley +1 more source
Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation. [PDF]
Niemi KJ +12 more
europepmc +1 more source
In this study, we developed a cost‐efficient neural probe by replacing traditional gold with an aluminum‐based Ti/Al/Ni multilayer stack. Optimizing this metal architecture suppressed oxidation and ensured robust electrical stability, achieving signal quality comparable to standard gold probes. It enables a highly accessible and economical solution for
Sehwan Park +6 more
wiley +1 more source
Exposure to Air Pollutants and Lewy Body and Parkinson Disease-Related Dementias.
Davydow DS +11 more
europepmc +1 more source
Feasibility for a Community-Based Parkinson Disease Cohort in Hawaii. [PDF]
Krening E +7 more
europepmc +1 more source
Blood‐based biomarkers are emerging as accessible tools for Alzheimer's disease screening, diagnosis, risk stratification, and longitudinal monitoring. This review summarizes major biomarkers, including Aβ42/Aβ40, phosphorylated tau species, NfL, GFAP, genetic risk markers, and exploratory inflammatory, synaptic, and proteomic candidates.
Shuangshuang Li, Lin Huang, Qihao Guo
wiley +1 more source
Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial.
Pahwa R +14 more
europepmc +1 more source
Midlife Vascular Risk Factors, Parkinson Disease, and Parkinson Disease-Dementia: The ARIC Study. [PDF]
Johri M +9 more
europepmc +1 more source

